Sökresultat

Rules of procedure for MultiPark

https://www.multipark.lu.se/about-multipark/multipark-steering-document - 2026-08-09

The Neuroscience graduate school seminars are held twice a month on Wednesdays at 12:00-13:00 in room I1345, BMC I13. This is your chance to hear about the research happening in the MultiPark research environment, as well as to socialize after the presentations. Seminars spring 202625 February11 March25 March6 May3 June17 June 

https://www.multipark.lu.se/lund-university-neuroscience-graduate-school/neuroscience-graduate-school-seminar-series - 2026-08-09

Distinguishing taupathies by kinetic analysis of reproducibility-optimized RT-quic experiments - Alexander DearPersonalized diagnosis and prognosis of Alzheimer´s disease - O Hansson, N Mattsson-Carlgren, S PalmqvistThe Alzheimer patient’s clinical cell biology - Hansson, Parmar, ToressonA new drug screening strategy for Huntington’s disease using induced neurons - Johan JakobssonPathophysiology-g

https://www.multipark.lu.se/innovation/innovation-projects-supported-multipark - 2026-08-09

Senior Researchers Ahlenius, Henrik - Stem Cells, Aging and NeurodegenerationBjörklund, Anders - affiliated with Developmental Neurobiology LabBjörklund, Tomas - Molecular Neuromodulation UnitBjörkqvist, Maria - Biomarkers in Brain DiseaseCenci Nilsson, Angela - Basal Ganglia PathophysiologyDeierborg, Tomas - NeuroinflammationEnglund, Elisabet - Division of Oncology and PathologyGouras, Gunnar - E

https://www.multipark.lu.se/research/research-groups - 2026-08-09

Our research We investigate how different parts of the central nervous system interact to generate purposeful behaviors. In particular, we study how the cerebral cortex and the basal ganglia interact to control motor actions, both under normal conditions and in individuals afflicted by Parkinson’s disease. In our previous work, we have studied motor control functions, ranging from relatively simpl

https://www.multipark.lu.se/integrative-neurophysiology-and-neurotechnology-lu-umu - 2026-08-09

MultiPark offers travel grants to PhD students and postdocs, but not for group leaders, senior lecturers, docents and above. Maximum two travel grants per applicant per calendar year.Maximum 18 000 SEK (including indirect costs) per applicant per calendar year. Maximum award for digital events is 3 000 SEK (including indirect costs).If awarded a travel grant, the recipient must agree on:Giving a l

https://www.multipark.lu.se/funding-opportunities/travel-grants - 2026-08-09

Our research investigates molecular, cellular, and circuit dysfunctions within the cortico–basal ganglia network. We aim to unravel cellular- and circuit-level changes that cause Parkinson’s disease (PD) symptoms and mediate treatment effects — both therapeutic effects and treatment complications, such as dyskinesia. Using experimental models, we elucidate core disease mechanisms and translate fin

https://www.multipark.lu.se/basal-ganglia-pathophysiology - 2026-08-09

Other strategic grants give you the opportunity to obtain co-funding when inviting scientific guests to give lectures or when organizing scientific conferences. The granted amount can be used to cover travel and accommodation costs in connection with the event. Please indicate if food/drinks are requested and indicate an amount. Costs for subsistence allowance (“traktamente”) are not eligible. Tri

https://www.multipark.lu.se/funding-opportunities/other-strategic-grants - 2026-08-09

Our research Our projects focus is to investigate the role of neuroinflammation in neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease and stroke. Microglia are the major immune cells in the brain. Therefore, the majority of our projects aim to explore the function of these cells and to determine how they contribute to health and disease. In addition, we investigate how

https://www.multipark.lu.se/experimental-neuroinflammation-laboratory - 2026-08-09

Dementia is a growing health concern worldwide as populations age. In Alzheimer’s disease and Parkinson’s disease, dementia is a major symptom that requires better therapies. These common diseases show overlapping/mixed dementia pathologies. Our group focus on the earliest subcellular pathological changes in synapses and is increasingly turning to therapeutic research, in particular immunotherapy,

https://www.multipark.lu.se/experimental-dementia-research - 2026-08-09

We develop novel microscale sample processing technologies for extracellular vesicle (EV) isolation from biofluids, e.g., CSF, enabling/facilitating EV-based biomarker profiling and discovery in minute sample volumes.Our projects provide access to bio-compartments for biomarker studies and discovery not readily available by standard methods. This contributes to the development of early and differe

https://www.multipark.lu.se/acoustofluidics-and-lab-chip - 2026-08-09

Our research includes people with neurodegenerative diseases and neurological conditions such as stroke, traumatic brain injury, spinal cord injury, and Parkinson’s disease. We use both quantitative and qualitative approaches to assess and understand the consequences of injury and disease from a lifelong perspective. Our focus is on these persons' impairments, activity limitations, participation r

https://www.multipark.lu.se/rehabilitation-medicine - 2026-08-09

Our research In the gene therapy group, our main interest is to develop systems for sufficient and sustained expression of transgenes in the CNS. We are using gene transfer to express trophic factors or neurotransmitter-producing enzymes in animal models of neurodegenerative disease. We are currently working with three different vector systems: adeno-associated viral, retroviral and lentiviral. Th

https://www.multipark.lu.se/cns-gene-therapy - 2026-08-09

Lund Brain Injury laboratory for Neurosurgical research The overarching aim of our research is to understand why traumatic brain injury is a risk factor for dementia and neurodegeneration. Athletes in contact sports have an increased risk of dementia and it appears that traumatic brain injury and head impacts in sports accelerate the dementia process. Traumatic brain injury and head impacts in spo

https://www.multipark.lu.se/translational-neurotrauma-group - 2026-08-09

We aim to develop and apply advanced MRI methods to quantify brain tissue microstructure in vivo, with a focus on neurodegenerative diseases. Our research combines diffusion MRI physics, experimental design, and learning-based reconstruction to disentangle cellular density, neurite architecture, and compartment-specific diffusion properties. We develop quantitative biomarkers sensitive to early pa

https://www.multipark.lu.se/microstructure-imaging-group - 2026-08-09

Our research aims to improve treatment, care, and quality of life for people with Parkinson’s disease and related atypical parkinsonian disorders by optimizing the detection, monitoring, and individualized management of both motor and non-motor symptoms. The work combines clinical, epidemiological, health-economic, and translational approaches, including registry-based studies, multicenter cohort

https://www.multipark.lu.se/restorative-parkinson-unit - 2026-08-09

Our research Organic Bioelectronic Neuropharmacology, electroceuticals for the nervous system - Our ambition is to supplement biochemical signaling with electronic functionalities using both galvanic (ion) and faradic (electron) processes. Traditional medicines are based on biochemical principles without regard to electrical properties. We focus on organic electronics that are self-assembled direc

https://www.multipark.lu.se/chemical-biology-therapeutics - 2026-08-09

Our research My group works with translational stem cell biology. The focus of my research is to understand cell fate specification in the developing brain and in human neural progenitor cells, using cell-based models of neuronal differentiation. Our current focus is to learn how to direct and efficiently drive controlled differentiation of human stem cells into subtype-specific neurons. We also d

https://www.multipark.lu.se/developmental-and-regenerative-neurobiology - 2026-08-09

Our research Neurovascular changes are now increasingly recognized as a common denominator of many neurodegenerative disorders. In my group, we examine how microvascular alterations at the blood-brain barrier contribute to the pathogenesis of neurodegeneration. Our special focus is on pericytes as key players in inflammation and neurodegeneration and potential target cells for brain repair. Using

https://www.multipark.lu.se/translational-neurology - 2026-08-09

We study Huntington’s disease, the spectrum of amyotrophic lateral sclerosis, and the behavioral variant of frontotemporal dementia. These are all fatal neurodegenerative disorders without disease-modifying therapies.Although research has previously focused on the well-known disturbances in motor function, emerging studies point to early non-motor features with altered emotional processing and met

https://www.multipark.lu.se/translational-neuroendocrinology - 2026-08-09